ScripScrip regularly covers business development and deal making in the biopharmaceutical industry. Asia Deal Watch is supported by deal intelligence from Biomedtracker. ProGen Partners With Rani To Devel
Pink SheetChina's National Medical Products Administration (NMPA) has just approved Genzyme Corp. 's injected enzyme replacement therapy Aldurazyme (laronidase) for the long-term treatment of patients with muc
ScripAfter announcing its first full-year results as a standalone company, Vifor Pharma Group has laid out ambitious growth plans to more than double sales by 2020, driven by two potential blockbusters –
ScripScrip regularly covers business development and deal-making in the biopharmaceutical industry. Below is a roundup of some of the most noteworthy recent transactions. Deal Watch is supported by deal in